Company / Revenue per Share
Wave Life Sciences Ltd. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.28
FY2025
5-year range
$0.28 / $1.30
FY2021-FY2025
Trend
-69.3%
vs FY2024
Sector context
#123 of 154
Health Care
What the data says
Wave Life Sciences Ltd.'s revenue per share of $0.28 is lower than 80% of companies in the Health Care sector (FY2025). Revenue per Share has fluctuated over the past 10 years, ranging from $0.03 in FY2017 to $1.30 in FY2023.
Based on SEC 10-K filings.
0.28 in FY2025 with a 5-year CAGR of -9.7%.
Declined from $1.30 to $0.28 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -25.8%
- 5-Year CAGR
- -9.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 154This company $0.28 Sector average $15.09
▼
-98.1% below sector average
Key checks
Key Insights
- In FY2025, revenue per share decreased 69.3% year-over-year.
- Ranks #123 out of 154 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2023.
- Lowest revenue per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.28 | -69.3% |
| FY2024 | $0.91 | -30.3% |
| FY2023 | $1.30 | +90.4% |
| FY2022 | $0.68 | +66.3% |
| FY2021 | $0.41 | -11.6% |
| FY2020 | $0.47 | +252.4% |
| FY2019 | $0.13 | -74.5% |
| FY2018 | $0.52 | +1700.7% |
| FY2017 | $0.03 | -58.3% |
| FY2016 | $0.07 | +1029.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026